MCID: PLS011
MIFTS: 56

Plasmacytoma malady

Categories: Cancer diseases, Neuronal diseases, Blood diseases, Rare diseases, Immune diseases

Aliases & Classifications for Plasmacytoma

Aliases & Descriptions for Plasmacytoma:

Name: Plasmacytoma 12 56 52 42 14 69
Solitary Plasmacytoma 12 56
Solitary Osseous Plasmacytoma 69
Plasmacytoma - Category 69
Myeloma - Solitary 12
Myeloma, Solitary 12
Solitary Myeloma 12

Characteristics:

Orphanet epidemiological data:

56
plasmacytoma
Inheritance: Not applicable; Age of onset: Adult; Age of death: elderly;

Classifications:



External Ids:

Disease Ontology 12 DOID:3721
ICD10 33 C90.3 C90.30
MeSH 42 D010954
NCIt 47 C6932 C9349
Orphanet 56 ORPHA86855
MESH via Orphanet 43 D010954
UMLS via Orphanet 70 C0032131
ICD10 via Orphanet 34 C90.2 C90.3
UMLS 69 C0032131

Summaries for Plasmacytoma

MalaCards based summary : Plasmacytoma, also known as solitary plasmacytoma, is related to nasopharyngitis and extramedullary plasmacytoma, and has symptoms including bone pain An important gene associated with Plasmacytoma is IL6 (Interleukin 6), and among its related pathways/superpathways are Innate Immune System and PAK Pathway. The drugs Cyclophosphamide and Lenograstim have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and thyroid, and related phenotypes are cellular and hematopoietic system

Wikipedia : 71 Plasmacytoma refers to plasma cell tumor growing within soft tissue or within the axial skeleton. There... more...

Related Diseases for Plasmacytoma

Diseases related to Plasmacytoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 212)
id Related Disease Score Top Affiliating Genes
1 nasopharyngitis 29.6 CD79A IL2 IL6
2 extramedullary plasmacytoma 12.2
3 anaplastic plasmacytoma 12.1
4 solitary osseous plasmacytoma 12.0
5 extramedullary soft tissue plasmacytoma 12.0
6 primary plasmacytoma of the bone 11.9
7 solitary plasmacytoma of chest wall 11.8
8 multiple myeloma 11.4
9 plasma cell neoplasm 11.1
10 polycystic bone disease 10.2 CCND1 NCAM1
11 thymic neuroendocrine carcinoma 10.2 IL2 IL6
12 dendritic cell thymoma 10.1 CD38 CD79A
13 thyroiditis 10.1
14 46 xy gonadal dysgenesis 10.1 B2M CD79A
15 post-surgical hypoinsulinemia 10.1 CCND1 IL2 MYC
16 clostridium difficile colitis 10.1 CD79A IL2 IL6
17 early yaws 10.1 B2M CD79A IL6
18 acute allergic sanguinous otitis media 10.1 B2M CCND1 IL2 IL6
19 central nervous system origin vertigo 10.1 B2M CD79A IL2
20 cystadenoma 10.1 IL2 MYC NCAM1
21 nonspecific interstitial pneumonia 10.1 CD79A IL2 IL6
22 pituitary carcinoma 10.1 CCND1 MYC NCAM1
23 venezuelan equine encephalitis 10.1 B2M CD38 CD79A
24 foodborne botulism 10.1 CD79A IL2 IL6
25 lymphoma 10.1
26 bone angioendothelial sarcoma 10.1 CD79A IL2 IL6
27 eye disease 10.1 CD27 CD79A
28 calcinosis 10.1 B2M CD79A IL6
29 atrial septal defect 6 10.0 CD79A IL2 IL6
30 somatostatinoma 10.0 B2M CD79A PTPRC
31 keratoconus 10.0 IL11 IL6 IL6R
32 ureter inverted papilloma 10.0 CD5 IL6
33 ovarian endometrioid cystadenoma 10.0 B2M CD27 PTPRC
34 membranoproliferative glomerulonephritis 10.0 CD79A IL2 IL6
35 akinetopsia 10.0 CD38 CD79A PTPRC
36 gingival recession 10.0 CCND1 CD27 MYC
37 autosomal dominant robinow syndrome 3 10.0 CD27 IL2 PTPRC
38 coloboma of eyelid 10.0 B2M CD5
39 scleral disease 10.0 CD27 CD79A IL2
40 verrucous carcinoma 10.0 B2M CD27 CD38 NCAM1
41 childhood brain stem glioma 10.0 CCND1 CD38 CD5
42 leukemia 10.0
43 cervicitis 9.9
44 amyloidosis 9.9
45 malignant pleural solitary fibrous tumor 9.9 CCND1 IL2 MYC
46 hemoglobinopathy 9.9 CCND1 CD5 IL2
47 barnicoat baraitser syndrome 9.9 CD38 CD5 MYC
48 parotitis 9.9 CCND1 CD5
49 duodenal ulcer 9.9 CD38 CD5 MYC
50 anus leiomyosarcoma 9.9 B2M CD38 CD79A IL2 IL6

Graphical network of the top 20 diseases related to Plasmacytoma:



Diseases related to Plasmacytoma

Symptoms & Phenotypes for Plasmacytoma

UMLS symptoms related to Plasmacytoma:


bone pain

MGI Mouse Phenotypes related to Plasmacytoma:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.14 CD27 CD38 CD79A IL2 IL6 IL6R
2 hematopoietic system MP:0005397 10.06 B2M CCND1 CD27 CD38 CD5 CD79A
3 immune system MP:0005387 10 B2M CCND1 CD27 CD38 CD5 CD79A
4 endocrine/exocrine gland MP:0005379 9.97 B2M CCND1 CD38 IL2 IL6 IL6R
5 liver/biliary system MP:0005370 9.7 B2M CD79A IL2 IL6 IL6R MYC
6 neoplasm MP:0002006 9.56 IL6 IL6R MYC PTPRC B2M CCND1
7 nervous system MP:0003631 9.28 B2M CCND1 CD5 CD79A IL6 IL6R

Drugs & Therapeutics for Plasmacytoma

Drugs for Plasmacytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 392)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
2
Lenograstim Approved Phase 4,Phase 3,Phase 2,Phase 1 135968-09-1
3
Thiotepa Approved Phase 4,Phase 2,Phase 1 52-24-4 5453
4 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1
5 Antilymphocyte Serum Phase 4,Phase 2,Phase 1
6 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1
7 Antirheumatic Agents Phase 4,Phase 3,Phase 1,Phase 2
8 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
9
Bortezomib Approved, Investigational Phase 3,Phase 2,Phase 1 179324-69-7 387447 93860
10
Dexamethasone Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 50-02-2 5743
11
Doxorubicin Approved, Investigational Phase 3,Phase 2,Phase 1 23214-92-8 31703
12
Melphalan Approved Phase 3,Phase 2,Phase 1 148-82-3 4053 460612
13
Vincristine Approved, Investigational Phase 3,Phase 2,Phase 1 2068-78-2, 57-22-7 5978
14
Prednisone Approved, Vet_approved Phase 3,Phase 1,Phase 2 53-03-2 5865
15
Idarubicin Approved Phase 3 58957-92-9 42890
16
Lomustine Approved Phase 3 13010-47-4 3950
17
Methylprednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 83-43-2 6741
18
Prednisolone Approved, Vet_approved Phase 3,Phase 2,Phase 1 50-24-8 5755
19
Carmustine Approved Phase 3,Phase 2,Phase 1 154-93-8 2578
20
Busulfan Approved, Investigational Phase 3,Phase 2,Phase 1 55-98-1 2478
21
Iron Approved Phase 3,Phase 2,Phase 1 7439-89-6 23925
22
Ketamine Approved, Vet_approved Phase 3 6740-88-1 3821
23
Lenalidomide Approved Phase 3,Phase 2,Phase 1 191732-72-6 216326
24
Cyclosporine Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 79217-60-0, 59865-13-3 5284373 6435893
25
Mycophenolate mofetil Approved, Investigational Phase 3,Phase 2,Phase 1 128794-94-5 5281078
26
Mycophenolic acid Approved Phase 3,Phase 2,Phase 1 24280-93-1 446541
27
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2,Phase 1 22916-47-8 4189
28
Zoledronic acid Approved Phase 3,Phase 1,Phase 2 118072-93-8 68740
29
Pamidronate Approved Phase 3,Phase 2,Phase 1 40391-99-9 4674
30
Darbepoetin alfa Approved, Investigational Phase 3,Phase 2 11096-26-7, 209810-58-2
31
Ondansetron Approved Phase 3 99614-02-5 4595
32
Dextromethorphan Approved Phase 3 125-71-3 5360696 5362449
33
Guaifenesin Approved, Vet_approved Phase 3 93-14-1 3516
34
Morphine Approved, Investigational Phase 3 57-27-2 5288826
35
Dalteparin Approved Phase 3 9041-08-1
36
Heparin Approved, Investigational Phase 3 9005-49-6 772 46507594
37
Amphotericin B Approved, Investigational Phase 3 1397-89-3 14956 5280965
38
deoxycholic acid Approved Phase 3 83-44-3 222528
39
Nystatin Approved, Vet_approved Phase 3 1400-61-9 11953884
40
Ephedrine Approved Phase 3 299-42-3 9294
41
Pseudoephedrine Approved Phase 3 90-82-4 7028
42
Amitriptyline Approved Phase 3 50-48-6 2160
43
Baclofen Approved Phase 3 1134-47-0 2284
44
Perphenazine Approved Phase 3 58-39-9 4748
45
Piperacillin Approved Phase 3 66258-76-2 43672
46
Tazobactam Approved Phase 3 89786-04-9 123630
47
Vancomycin Approved Phase 3 1404-90-6 441141 14969
48
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
49
Caspofungin Approved Phase 3,Phase 2 179463-17-3, 162808-62-0 468682 2826718
50 Ixazomib Approved Phase 3,Phase 2 1072833-77-2

Interventional clinical trials:

(show top 50) (show all 379)
id Name Status NCT ID Phase
1 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4
2 CDD Plus Bortezomib or CDDin Relapsed or Refractory Multiple Myeloma With Extramedullary Plasmacytoma Unknown status NCT02336386 Phase 3
3 High-Dose Melphalan and a Second Stem Cell Transplant or Low-Dose Cyclophosphamide in Treating Patients With Relapsed Multiple Myeloma After Chemotherapy Unknown status NCT00747877 Phase 3
4 Combination Chemotherapy With or Without Thalidomide in Treating Patients With Multiple Myeloma Unknown status NCT00028886 Phase 3
5 Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma Unknown status NCT00014339 Phase 3
6 Chemotherapy Plus Steroid Therapy in Treating Patients With Multiple Myeloma Unknown status NCT00003603 Phase 3
7 Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma Unknown status NCT00002653 Phase 3
8 Combination Chemotherapy and Interferon Alfa With or Without Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloma Unknown status NCT00002599 Phase 3
9 Comparable Investigation of One Fraction Radiotherapy and Multifraction Radiotherapy in Patients With Multiple Myeloma. Unknown status NCT02024815 Phase 3
10 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3
11 Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer Unknown status NCT00482716 Phase 3
12 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3
13 Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma Completed NCT00432458 Phase 3
14 Thalidomide and Prednisone After Autologous Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00049673 Phase 3
15 Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma Completed NCT00033332 Phase 3
16 Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma Completed NCT00017602 Phase 3
17 Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00008229 Phase 3
18 Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma Completed NCT00006232 Phase 3
19 Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma Completed NCT00004165 Phase 3
20 Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma Completed NCT00002878 Phase 3
21 Combination Chemotherapy in Treating Patients With Multiple Myeloma Completed NCT00002678 Phase 3
22 Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis Completed NCT00477971 Phase 3
23 S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma Completed NCT00064038 Phase 3
24 Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure Completed NCT00416897 Phase 3
25 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3
26 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3
27 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3
28 Treatment for Chronic Pain in Patients With Advanced Cancer Completed NCT00003687 Phase 3
29 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3
30 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
31 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
32 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3
33 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
34 Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy Completed NCT00003341 Phase 3
35 Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102) Completed NCT00075829 Phase 3
36 Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer Completed NCT00002742 Phase 3
37 Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer Completed NCT00265837 Phase 3
38 Epoetin Alfa in Treating Anemia in Patients With Solid Tumors Completed NCT00058331 Phase 3
39 Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy Completed NCT00003600 Phase 3
40 Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder Completed NCT00755040 Phase 3
41 Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer Completed NCT00516503 Phase 3
42 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3
43 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3
44 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3
45 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3
46 Trial of Immunomodulatory Therapy in High Risk Solitary Bone Plasmacytoma Recruiting NCT02544308 Phase 3
47 Ixazomib Citrate, Lenalidomide, Dexamethasone, and Zoledronic Acid or Zoledronic Acid Alone After Radiation Therapy in Treating Patients With Solitary Plasmacytoma of Bone Recruiting NCT02516423 Phase 3
48 Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma Active, not recruiting NCT02136134 Phase 3
49 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3
50 Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Unknown status NCT00742404 Phase 2

Search NIH Clinical Center for Plasmacytoma

Cochrane evidence based reviews: plasmacytoma

Genetic Tests for Plasmacytoma

Anatomical Context for Plasmacytoma

MalaCards organs/tissues related to Plasmacytoma:

39
Bone, Bone Marrow, Thyroid, Breast, Colon, Lung, Pancreas

Publications for Plasmacytoma

Articles related to Plasmacytoma:

(show top 50) (show all 1013)
id Title Authors Year
1
Oral extramedullary plasmacytoma in a HIV positive patient. ( 27894848 )
2017
2
Solitary plasmacytoma: population-based analysis of survival trends and effect of various treatment modalities in the USA. ( 28056880 )
2017
3
Epibulbar Plasmacytoma Masquerading as Subconjunctival Hemorrhage in a Patient With Multiple Myeloma. ( 28060076 )
2017
4
Solitary extraosseous plasmacytoma. ( 27648261 )
2016
5
Extramedullary Plasmacytoma of the Oral Cavity in a Young Man: a Case Report. ( 27284562 )
2016
6
Primary pulmonary plasmacytoma mimicking lung cancer diagnosed on endobronchial ultrasound (EBUS)-guided biopsy. ( 27302639 )
2016
7
Atrophoderma of Pasini and Pierini associated with extramedullary plasmacytoma. ( 27443586 )
2016
8
Comparison of intramedullary myeloma and corresponding extramedullary soft tissue plasmacytomas using genetic mutational panel analyses. ( 27206246 )
2016
9
Extramedullary Plasmacytoma Diagnosed in an HIV-Positive Patient by an Unusual Clinical Presentation. ( 27980867 )
2016
10
Retroperitoneal laparoscopic management of a solitary extramedullary plasmacytoma associated with human immunodeficiency virus infection: A case report. ( 26870281 )
2016
11
Solitary Plasmacytoma of the Mandible: An Uncommon Entity. ( 27651943 )
2016
12
Elderly man with a pulmonary mass and osteolytic lesions: is it primary pulmonary plasmacytoma or multiple myeloma with an extramedullary pulmonary nodule? ( 27358101 )
2016
13
Extramedullary Plasmacytoma of the Gallbladder Detected on Fluorine 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. ( 27761300 )
2016
14
Bilateral synchronous plasmacytoma of the testis. ( 27034568 )
2016
15
Primary pulmonary plasmacytoma: a case report introduction. ( 27487779 )
2016
16
Successful treatment of a primary gastric plasmacytoma mimicking intractable gastric ulcer by using high-dose dexamethasone therapy: a case report. ( 27036197 )
2016
17
Plasmablastic plasmacytoma-like post-transplant lymphoproliferative disorder in an orthotopic liver transplant. ( 27133968 )
2016
18
Extramedullary plasmacytoma of the gingiva. ( 26887880 )
2016
19
Extramedullary Plasmacytoma of the Maxilla Simulating a Maxillary Radicular Cyst: Quick Diagnosis and Management. ( 27054435 )
2016
20
Multiple primary cutaneous plasmacytoma a decade after a nasal solitary extramedullary plasmacytoma: a puzzling case. ( 27980740 )
2016
21
Feline Respiratory Extramedullary Plasmacytoma with Lymph Node Metastasis and Intrahistiocytic Amyloid. ( 28017340 )
2016
22
Extramedullary Plasmacytoma Presenting With Acute Airway Compromise, Treated With Emergent Rigid Bronchoscopic Resection. ( 27058726 )
2016
23
Transcriptional profiling identifies the long noncoding RNA plasmacytoma variant translocation (PVT1) as a novel regulator of the asthmatic phenotype in human airway smooth muscle. ( 27484035 )
2016
24
Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2-/- mouse long-term bone marrow cultures. ( 27637088 )
2016
25
Fast-Growing Plasmacytoma. ( 26992263 )
2016
26
Extramedullary Plasmacytoma of the Paranasal Sinuses: Combining Surgery with External Radiotherapy. ( 27066407 )
2016
27
Plasmacytoma of the testis in a patient with previous multiple myeloma: sonographic appearance. ( 27298651 )
2016
28
Giant intracranial solitary plasmacytoma. ( 27531229 )
2016
29
Solitary Bone Plasmacytoma of the Pelvis: A Rare Tumor. ( 27134717 )
2016
30
Collision Tumor With Renal Cell Carcinoma and Plasmacytoma: Further Evidence of a Renal Cell and Plasma Cell Neoplasm Relationship? ( 27175345 )
2016
31
Clinical risk factors of Plasmacytoma mortality: a US population-based study. ( 27291254 )
2016
32
Isolated nerve plasmacytoma in a patient previously in systemic myeloma remission. ( 28029682 )
2016
33
Multiple myeloma: Presenting as intracranial plasmacytoma. ( 28017323 )
2016
34
Solitary Extramedullary Plasmacytoma of the Maxillary Sinus, Progressing to Smoldering Multiple Myeloma with Multifocal Skeletal Involvement, which Resolved Completely Following Chemotherapy Alone. ( 27408443 )
2016
35
Gastric adenocarcinoma concurrent with paravertebral plasmacytoma: A case report. ( 27446469 )
2016
36
Successful treatment of primary advanced gastric plasmacytoma using a combination of surgical resection and chemotherapy with bortezomib: A case report. ( 27611798 )
2016
37
Bilateral breast plasmacytoma: a clinical case report. ( 27208578 )
2016
38
A Case of Cardiac Light Chain Deposition Disease in a Patient with Solitary Plasmacytoma. ( 26988342 )
2016
39
Establishment of an innovative staging system for extramedullary plasmacytoma. ( 27717354 )
2016
40
Primary Plurifocal Extramedullary Plasmacytoma of Breast. ( 27059937 )
2016
41
Survival Analyses and Prognosis of Plasma-Cell Myeloma and Plasmacytoma-Like Posttransplantation Lymphoproliferative Disorders. ( 27771291 )
2016
42
Intestinal plasmacytoma causing colocolic double intussusception in an adult dog. ( 27925660 )
2016
43
Primary Extramedullary Plasmacytoma in the Gastroduodenal Canal Associated With Epstein-Barr Virus-Associated Adenocarcinoma of the Stomach: A Case Report. ( 27466321 )
2016
44
Progression of a solitary plasmacytoma to multiple myeloma. A population-based registry of the northern Netherlands. ( 27605358 )
2016
45
Unusual Cause of Sphenoidal Sinus Mass: Extramedullary Plasmacytoma. ( 27779089 )
2016
46
Neuro-ophthalmic presentations of clival plasmacytoma. ( 27085275 )
2016
47
Solitary Plasmacytoma of the Petrous Apex: A Case Report and Review of Literature. ( 27295445 )
2016
48
Orbital Plasmacytoma Mimicking an Orbital Abscess. ( 27046038 )
2016
49
Epibulbar Plasmacytoma Masquerading as Subconjunctival Hemorrhage in a Patient With Multiple Myeloma. ( 27861307 )
2016
50
Miniature brain in spine: the 'mini brain sign' in vertebral plasmacytoma. ( 27307469 )
2016

Variations for Plasmacytoma

Expression for Plasmacytoma

Search GEO for disease gene expression data for Plasmacytoma.

Pathways for Plasmacytoma

Pathways related to Plasmacytoma according to GeneCards Suite gene sharing:

(show all 28)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.89 B2M CCND1 CD27 CD79A IL11 IL2
2
Show member pathways
13.17 CD27 IL11 IL2 IL6 IL6R PTPRC
3
Show member pathways
13.13 B2M CCND1 CD27 IL11 IL2 IL6
4
Show member pathways
12.48 IL2 IL6 IL6R MYC
5 12.48 CCND1 IL2 IL6 IL6R MYC
6 12.38 B2M CD38 CD79A IL2 NCAM1 PTPRC
7 12.33 CCND1 IL2 IL6 MYC
8 12.09 CCND1 IL6 IL6R MYC
9 11.95 IL11 IL6 MYC NCAM1
10 11.87 CCND1 IL2 IL6 MYC
11
Show member pathways
11.87 CCND1 IL11 IL2 IL6 IL6R MYC
12 11.84 CCND1 IL6 IL6R MYC
13
Show member pathways
11.74 IL6 IL6R MYC
14 11.74 CD79A IL6 NCAM1 PTPRC
15 11.71 CD38 CD5 IL11 IL6 IL6R
16 11.7 IL2 NCAM1 PTPRC
17 11.61 IL2 IL6 IL6R
18 11.6 CCND1 IL2 MYC
19
Show member pathways
11.57 CCND1 IL2 IL6
20 11.54 CD38 IL2 IL6 NCAM1 PTPRC
21
Show member pathways
11.53 IL11 IL6 IL6R
22 11.47 CCND1 IL2 IL6
23 11.44 CCND1 IL6 IL6R MYC
24 11.43 IL11 IL6 IL6R
25 11.29 CD38 CD5 CD79A IL11 IL2 IL6
26 11.26 CCND1 IL6 MYC
27 11.16 IL11 IL2 IL6
28 11.08 CD27 CD38 CD5 IL6R PTPRC

GO Terms for Plasmacytoma

Cellular components related to Plasmacytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.86 B2M CD27 CNTN3 IL11 IL2 IL6
2 cell surface GO:0009986 9.43 B2M CD27 CD38 IL6R NCAM1 PTPRC
3 external side of plasma membrane GO:0009897 9.17 B2M CD27 CD5 CD79A IL6 NCAM1
4 interleukin-6 receptor complex GO:0005896 9.16 IL6 IL6R

Biological processes related to Plasmacytoma according to GeneCards Suite gene sharing:

(show all 23)
id Name GO ID Score Top Affiliating Genes
1 negative regulation of apoptotic process GO:0043066 9.92 CD27 CD38 IL2 IL6 MYC
2 response to estradiol GO:0032355 9.77 CCND1 CD38 MYC
3 B cell receptor signaling pathway GO:0050853 9.76 CD38 CD79A PTPRC
4 positive regulation of peptidyl-tyrosine phosphorylation GO:0050731 9.73 IL11 IL6 IL6R
5 positive regulation of T cell proliferation GO:0042102 9.69 IL2 IL6 PTPRC
6 response to cytokine GO:0034097 9.67 CD38 IL6 IL6R
7 positive regulation of smooth muscle cell proliferation GO:0048661 9.65 IL6 IL6R MYC
8 response to drug GO:0042493 9.65 B2M CCND1 CD38 IL6 MYC
9 defense response to Gram-negative bacterium GO:0050829 9.63 B2M IL6 IL6R
10 positive regulation of T cell differentiation GO:0045582 9.61 CD27 IL2
11 positive regulation of chemokine production GO:0032722 9.61 IL6 IL6R
12 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.61 IL2 IL6 IL6R
13 negative regulation of bone resorption GO:0045779 9.59 CD38 IL6
14 positive regulation of leukocyte chemotaxis GO:0002690 9.58 IL6 IL6R
15 positive regulation of immunoglobulin secretion GO:0051024 9.57 IL2 IL6
16 negative regulation of hormone secretion GO:0046888 9.55 IL11 IL6
17 interleukin-6-mediated signaling pathway GO:0070102 9.54 IL6 IL6R
18 positive regulation of B cell proliferation GO:0030890 9.54 CD38 IL2 PTPRC
19 response to ethanol GO:0045471 9.46 CCND1 CD27 IL2 MYC
20 re-entry into mitotic cell cycle GO:0000320 9.4 CCND1 MYC
21 cellular response to prolactin GO:1990646 9.32 IL6 MYC
22 positive regulation of cell proliferation GO:0008284 9.1 CCND1 IL11 IL2 IL6 IL6R MYC
23 hepatic immune response GO:0002384 8.96 IL6 IL6R

Molecular functions related to Plasmacytoma according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 interleukin-6 receptor binding GO:0005138 8.62 IL6 IL6R

Sources for Plasmacytoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....